Real-life experience with the implementation of DLL3 staining and the subsequent treatment with rovalpituzumab tesirine in heavily pretreated SCLC patients
Title:
Real-life experience with the implementation of DLL3 staining and the subsequent treatment with rovalpituzumab tesirine in heavily pretreated SCLC patients
Author:
Hochmair, M.J. Weinlinger, C. Fabikan, H. Koger, R. Krenbeck, D. Huemer, F. Illini, O.M. Kulaksiz, M. Valipour, A. Burghuber, O.C.